Lifetime cardiovascular risk
Gray, B.
New Zealand Medical Journal 124(1336): 96
2011
ISSN/ISBN: 0028-8446 PMID: 21946751 Document Number: 652542
Document emailed within 1 workday
Related Documents
Knopp, R.H. 1988: Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime American Journal of Obstetrics and Gynecology 158(6 Part 2): 1630-1643Kleber, M.E.; Winkler, K.; Wolfert, R.L.; Delgado, G. de Moissl; Grammer, T.B.; Dietz, S.; Winkelmann, B.R.; Boehm, B.O.; Winfried März 2011: Lipoprotein Associated Phospholipase A2 Concentration Predicts Total and Cardiovascular Mortality Independently of Established Risk Factors (The Ludwigshafen Risk and Cardiovascular Health Study) Clinical Laboratory 57(9-10): 659-667
Baena Díez, Jé.Miguel.; Del Val García, Jé.Luis.; Alemany Vilches, L.; Martínez Martínez, Jé.Luis.; Tomàs Pelegrina, J.; González Tejón, Ián.; Raidó Quintana, E.María.; Rovira España, Mónica. 2005: Risk of Suffering from Cardiovascular Diseases because of the Clustering of the Modifiable Cardiovascular Risk Factors in the Population Older than 15 years of a Health Care Center in Barcelona Revista espanola de salud publica 79: 365-378
Haderxhanaj, L.T.; Leichliter, J.S.; Aral, S.O.; Chesson, H.W. 2014: Sex in a lifetime: Sexual behaviors in the United States by lifetime number of sex partners, 2006-2010 Sexually transmitted diseases 41(6): 345-352
Osler, M.; Jespersen, N.B.; Lous, J.; Rasmussen, N.K. 1992: Cardiovascular risk factors--extent and self-assessed risk in relation to prevention of cardiovascular diseases. A questionnaire among 3,956 men and women aged 24-65 years in Vejle County, Slangerup and Helsinge municipalities Ugeskrift for Laeger 154(9): 538-543
Daowd, A.; Abidi, S.R.; Abusharekh, A.; Abidi, S.S.R. 2018: A Personalized Risk Stratification Platform for Population Lifetime Healthcare Studies in Health Technology and Informatics 247: 920-924
Heinemann, L.A.J.; Lewis, M.A.; Kuhlhabich, D.; Braendle, W.; Moehner, S.; G C, E.M.A.N.N. L.A.J. 2002: The risk of breast tumours and lifetime history of oral contraceptive use Geburtshilfe und Frauenheilkunde 62(8): 750-757
Grant, E.C.G. 2017: Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy American Journal of Obstetrics and Gynecology 217(2): 232-233
Feng, H.; Song, G.; Yang, J.; Hao, C.; Wang, M.; Li, B.; Zhao, D.; Liu, Z.; Wei, W.; Qiao, Y. 2015: Cost-effectiveness analysis of esophageal cancer once-in-a-lifetime endoscopic screening in high-risk areas of rural China Zhonghua Zhong Liu Za Zhi 37(6): 476-480
Gureje, O.; Uwakwe, R.; Udofia, O.; Wakil, A.; Adeyemi, O.; Enyidah, N. 2008: Common psychiatric disorders over a lifetime: age of onset, risk and treatment contact in the Nigerian survey of mental health and wellbeing African Journal of Medicine and Medical Sciences 37(3): 207-217
Palmieri, L.; Trojani, M.; Vanuzzo, D.; Panico, S.; Pilotto, L.; Dima, F.; Noce, C.L.; Uguccioni, M.; Pede, S.; Giampaoli, S. 2005: Distribution of the global cardiovascular risk in the Italian population: results from the cardiovascular epidemiologic observatory Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 6(5): 279-284
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558
Fleming, P.J.; McCleary-Sills, J.; Morton, M.; Levtov, R.; Heilman, B.; Barker, G. 2015: Risk factors for men's lifetime perpetration of physical violence against intimate partners: results from the international men and gender equality survey (IMAGES) in eight countries Plos one 10(3): E0118639
Fleming, P.J.; McCleary-Sills, J.; Morton, M.; Levtov, R.; Heilman, B.; Barker, G. 2015: Risk factors for men's lifetime perpetration of physical violence against intimate partners: results from the international men and gender equality survey (IMAGES) in eight countries Plos one 10(3): E0118639
Vrhovski, D.; Mestrić, Z.; Subić, N.; Surina, B.; Kranjcević, S. 1985: Established risk factors and complementary risk factors as additional parameters in evaluating the risk of cardiovascular diseases Lijecnicki Vjesnik 107(11-12): 481-484
Fellah, H.; Feki, M.; Feki, H.; Souissi, M.; Kaabachi, N.; Abdallah, T.B.; Massy, Z.A.; Maiz, H.B.; Lacour, B.; Mebazaa, A. 2004: Classical and "Non-classical" Cardiovascular Risk Factors in Tunisian Patients with End Stage Renal Disease: Prevalence and Association with Cardiovascular Events Clinical Laboratory 50(7-8): 447-453
Oksa, A. 2006: Cardiovascular risk in patients with chronic kidney diseases: a time for new risk markers? Bratislavske Lekarske Listy 107(8): 314-319
Tonstad, S. 1998: Should treatment of risk factors of cardiovascular diseases be directed only by absolute risk? Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(19): 2966-2968
Elliott, H.L. 1998: Endothelial dysfunction in cardiovascular disease: risk factor, risk marker, or surrogate end point? Journal of Cardiovascular Pharmacology 32(Suppl 3): S74-S77
Edwards-Jackson, N.; Kerr, S.; Tieu, H.; Ananworanich, J.; Hammer, S.; Ruxrungtham, K.; Phanuphak, P.; Avihingsanon, A. 2011: Cardiovascular risk assessment in persons with HIV infection in the developing world: comparing three risk equations in a cohort of HIV-infected Thais HIV Medicine 12(8): 510-515